Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer (GEST)
Randomized Phase III Study of Gemcitabine Versus TS-1 Versus Gemcitabine Plus TS-1 in Unresectable Advanced Pancreatic Cancer (With Local Progression or Metastasis)
Sponsor: TTY Biopharm
This PHASE3 trial investigates Pancreatic Cancer and is currently completed. TTY Biopharm leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jul 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- TTY Biopharm
- Taiho Pharmaceutical Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No.100, Tzyou 1st Rd., Kaohsiung, Taiwan , No.123, Ta-Pei Rd., Niao-Sung Hsiang, Kaohsiung Hsien, Taiwan , No.135, Nanxiao St., Changhua, Taiwan , No.138, Sheng Li Road,Tainan, Taiwan , No.2, Yuh-Der Rd.,Taichung, Taiwan , No.201, Sec. 2, Shih-Pai Road, Taipei, Taiwan , No.201, Taikang Village, Liou Ying Township, Tainan, Taiwan , No.5, Fu-Hsing Saint Kuei Shan Hsiang, Taoyuan Hsien, Taiwan , No.7, Chung San South Road, Taipei, Taiwan , No.901, Chung Hwa Rd., Yong Kang City, Tainan, Taiwan and 2 more locations